Friday, June 3, 2016 | 8:30 AM - 6:00 PM
Speakers: Seamus Fanning (University College Dublin), Delia Grace (International Livestock Research Institute), William J. Hall (Wellcome Trust), Rebecca Irwin (Public Health Agency of Canada), Francois Malouin (Sherbrooke University), James L. Marsden (Chipotle Mexican Grill), Alan G. Mathew (Purdue University), H. Morgan Scott (Texas A&M University), Stacy E. Sneeringer (USDA), Jaap A. Wagenaar (Utrecht University), and David R. Wolfgang (Pennsylvania State University)
Antibiotics have been used in human and animal medicine for decades. Reducing the use of antibiotics changes the dynamic between the food supply, food safety, and public health. Food safety practices may emerge a catalyst for change.
Monday, June 6, 2016 | 1:30 PM - 4:30 PM
Keynote Speaker: John Diffley (The Francis Crick Institute)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity, and onset and progression of malignancy.
Monday, June 13, 2016 | 10:00 AM - 3:30 PM
Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)
This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.
Tuesday, June 21, 2016 | 8:00 AM - 5:00 PM
Keynote Speaker: Sharon Inouye (Harvard Medical School)
This meeting will convene leading scientists and physicians to discuss the challenges and opportunities to create biomarkers and therapeutics for these patients who are vulnerable to delirium, cognitive decline, and dementia following surgery.
Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM
Keynote Speaker: Giancarlo Comi (Universitè Vita-Salute San Raffaele)
Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.
Thursday, May 26, 2016 | 9:00 AM - 6:00 PM
Featured Speaker: Peter Godfrey-Faussett (UNAIDS)
This event will address the incidence of non-communicable diseases among people living with HIV, describe morbidity and mortality, and explore interactions among HIV, antiretroviral drugs and behavioral factors influencing development and treatment.
Wednesday, May 25, 2016 | 11:30 AM - 5:00 PM
Speakers: Philip A. Cole (Johns Hopkins University School of Medicine), Kenneth W. Duncan (Epizyme, Inc.)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2016, the annual year-end meeting features keynote speakers Dr Philip Cole and Dr Kenneth Duncan.
May 18 - 20, 2016
Keynote Speakers: Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), and The Honorable Patrick J. Kennedy (Former United States Representative, Rhode Island; Co-Founder, One Mind; and Founder, Kennedy Forum)
Discover from leading experts, including NIAAA and NIDA directors, the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.
Wednesday, May 18, 2016 | 5:45 PM - 7:00 PM
Moderator: Claudia Wallis (Scientific American Mind)
Panelists: Jeremy Waletzky (The George Washington University), Nora D. Volkow (NIH), Cheryl Healton (College of Global Public Health, New York University), and Honorable Gregory P. Canova, JD
1.3 million adolescents in the US have substance use disorder and marijuana use among teens now exceeds cigarette smoking. Join us for a public panel discussion on how neuroscience intersects with policy to improve lives of teens with addiction.
Organizers: John Hambor (Boehringer Ingelheim), Sarkis Mazmanian (California Institute of Technology), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing discusses gut–brain interactions and the possibility of targeting the microbiome with a focus on CNS health.
Organizers: Renier Brentjens (Memorial Sloan Kettering Cancer Center), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing explores advances in cancer immunotherapy, which engages the immune system to detect and destroy cancer cells and has gained popularity and success in recent years.
Organizers: Jane S. Lebkowski (Asterias Biotherapeutics), George Zavoico (JonesTrading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing considers efforts to rethink clinical, regulatory, and manufacturing approaches to accelerate the transition of cell-based therapies to the clinic.
Edited by Annals of the New York Academy of Sciences
Continuation of over four decades of scientific discussion on Cooley's anemia published in Annals of the New York Academy of Sciences